TNF and interstitial lung disease: Anti-TNF agents have been mostly associated with DILD or exacerbation of a preexisting ILD, as well as being frequently associated with infectious and noninfectious granulomatous lung disease, DAD, and, less often, pulmonary fibrosis and OP.15